| Name | Title | Contact Details |
|---|
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.
With a growing demand for behavioral health services and a shortage of providers, access to care is challenging. Telepsychiatry is a solution to bridge this gap in care. innovaTel has nationwide network of psychiatrists, nurse practitioners and licensed clinical social workers that connect to organizations virtually through telemedicine.
Helix Medical Communications is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Holland Applied Technologies is a Burr Ridge, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Advanced Sterilization Products is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.